Authors:
Lehtinen, M
Kibur, M
Luostarinen, T
Anttila, A
Pukkala, E
Citation: M. Lehtinen et al., Prospects for phase III-IVHPV vaccination trials in the Nordic countries and in Estonia, J CLIN VIRO, 19(1-2), 2000, pp. 113-122
Authors:
Kibur, M
af Geijerstamm, V
Pukkala, E
Koskela, P
Luostarinen, T
Paavonen, J
Schiller, J
Wang, Z
Dillner, J
Lehtinen, M
Citation: M. Kibur et al., Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination, SEX TRANS I, 76(1), 2000, pp. 13-17
Authors:
Hakama, M
Luostarinen, T
Hallmans, G
Jellum, E
Koskela, P
Lehtinen, M
Thoresen, S
Youngman, L
Hakulinen, T
Citation: M. Hakama et al., Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries), CANC CAUSE, 11(9), 2000, pp. 783-790
Authors:
Koskela, P
Anttila, T
Bjorge, T
Brunsvig, A
Dillner, J
Hakama, M
Hakulinen, T
Jellum, E
Lehtinen, M
Lenner, P
Luostarinen, T
Pukkala, E
Saikku, P
Thoresen, S
Youngman, L
Paavonen, J
Citation: P. Koskela et al., Chlamydia trachomatis infection as a risk factor for invasive cervical cancer, INT J CANC, 85(1), 2000, pp. 35-39
Authors:
Teppo, L
Dickman, PW
Hakulinen, T
Luostarinen, T
Pukkala, E
Sankila, R
Soderman, B
Citation: L. Teppo et al., Cancer patient survival - Patterns, comparisons, trends - A population-based cancer registry study in Finland, ACTA ONCOL, 38(3), 1999, pp. 283-294
Authors:
Lehtinen, M
Luostarinen, T
Youngman, LD
Anttila, T
Dillner, J
Hakulinen, T
Koskela, P
Lenner, P
Hallmans, G
Citation: M. Lehtinen et al., Low levels of serum vitamins A and E in blood and subsequent risk for cervical cancer: Interaction with HPV seropositivity, NUTR CANCER, 34(2), 1999, pp. 229-234
Authors:
Luostarinen, T
af Geijersstam, V
Bjorge, T
Eklund, C
Hakama, M
Hakulinen, T
Jellum, E
Koskela, P
Paavonen, J
Pukkala, E
Schiller, JT
Thoresen, S
Youngman, LD
Dillner, J
Lehtinen, M
Citation: T. Luostarinen et al., No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11, INT J CANC, 80(6), 1999, pp. 818-822